Device Trial Radar · NCT04846127
CanGaroo® Registry Study
Last checked: Nov 19, 2026Latest source record: May 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
500
Actual
Start
May 25, 2021
Primary completion
Apr 17, 2023
Study completion Oct 17, 2024
Sponsor
- Lead sponsor
- Elutia Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 15, 2021
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Multi-Center Registry Evaluating Participants Who Receive CanGaroo Envelope or No Envelope During their CIED Implantation
Conditions
- Arrhythmias, Cardiac
Interventions
CanGaroo EnvelopeDevice
Utilization of a CanGaroo envelope with the CIED during the participant's CIED implant procedure.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Association between participant characteristics and outcomesTime frame: 3 months post-procedure
- Association between CanGaroo envelope use and CIED implant-related outcomes and events.Time frame: 3 months post-procedure
Locations
23 sites in 1 country. Site status is shown where the registry gives one.
Arkansas Heart Hospital
Little Rock, Arkansas
Daytona Heart Group
Daytona Beach, Florida
The Arrhythmia Center of South Florida
Delray Beach, Florida
20 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.